Colon cancer screening

Gastroenterology

Volumn 119, Issue 3, 2000, Pages 837-853

  Burt, Randall W ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BARIUM ENEMA; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; CONTRAST ENHANCEMENT; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COWDEN SYNDROME; DIAGNOSTIC TEST; FAMILIAL POLYPOSIS; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; OCCULT BLOOD TEST; PEUTZ JEGHERS SYNDROME; PRACTICE GUIDELINE; PRIORITY JOURNAL; SIGMOIDOSCOPY;

EID: 0033864291     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2000.16508     Document Type: Article

References (121)

1. Occult blood screening for colorectal cancer
2. Sigmoidoscopy in the periodic health examination of asymptomatic adults
3. Cancers statistics, 2000
4. Harvard report on cancer prevention. Volume 3. Prevention of colon cancer in the United States
5. Detection and surveillance of colorectal cancer
6. Reducing mortality from colorectal cancer by Screening for fecal occult blood
7. Randomized controlled trial of faecal-Foccult-blood screening for colorectal cancer
8. Randomised study of screening for colorectal cancer with faecal-occult blood test
9. Screening for colorectal cancer with fecal occult blood test: A background paper
10. Colorectal cancer mortality: Effectiveness of biennial screening for fecal occult blood
11. Effect of fecal occult blood testing on mortality from colorectal cancer: A case-control study
12. Effectiveness of colorectal cancer screening: Results from a population-based case-control evaluation in Saarland, Germany
13. Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy
14. Fecal occult blood screening for colorectal cancer. Is mortality reduced by chance selection for screening colonoscopy?
15. Screening for colorectal cancer: Which test is best?
16. Fecal occult blood screening in the Minnesota study: Role of chance detection of lesions
17. Fecal occult blood screening in the Minnesota study: Sensitivity of the screening test
18. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer
19. Screening sigmoidoscopy and colorectal cancer mortality
20. Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case-control study of 32,702 veterans
21. Prevention of colorectal cancer by colonoscopic polypectomy
22. Colorectal cancer screening clinical guidelines and rationale
23. American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: Update 1997
24. Colonoscopy versus barium enema in the diagnosis of colorectal cancer and polyps
25. Relative sensitivity of colonoscopy and barium enema for detection of colorectal cancer in clinical practice
26. Prospective determination of distal colon findings in average-risk patients with proximal colon cancer
27. Is colonoscopy needed for the nonadvanced adenoma found on sigmoidoscopy
28. Population-based colonoscopy screening for colorectal cancer is feasible and safe: Preliminary results from the VA colonoscopy screening trial
29. Cost-effectiveness model for colon cancer screening
30. Screening colonoscopy in average risk individuals is cost-effective compared with other practices
31. Cost-effectiveness of colorectal cancer screening in average-risk adults
32. Screening for colorectal cancer - United States, 1992-1993, and New Guidelines
33. Screening for colorectal cancer - United States, 1997
34. A comparison of fecal occult blood tests for colorectal cancer screening
35. Detection of altered DNA in stool: Feasibility for colorectal neoplasia screening
36. A comparison of virtual and conventional colonoscopy for the detection of colorectal polyps
37. NCCN colorectal cancer screening practice guidelines. National Comprehensive Cancer Network
38. A genetic study of carcinoma of the large intestine
39. Inheritance of cancer of the stomach and large intestine in man
40. Family studies in cancer of the colon and rectum
41. Family incidence of carcinoma of the colon and rectum in north-east Scotland
42. Familial occurrence of cancer of the colon and the rectum: Results of a 3-year survey
43. Incidence and familial occurrence of colorectal cancer and polyps in a health care district of northern Italy
44. The Melbourne colorectal cancer study. Characterization of patients with a family history of colorectal cancer
45. Family history of colorectal cancer as a risk factor for benign and malignant tumours of the large bowel. A case-control study
46. Frequency of familial colorectal cancer
47. A Prospective study of family history and risk of colorectal cancer
48. Risk of colorectal cancer in the families of patients with adenomatous polyps
49. Family history of colorectal adenomatous polyps and increased risk for colorectal Cancer
50. Screening of patients with a positive family history of colorectal cancer
51. Screening asymptomatic patients at high risk for colon cancer with full colonoscopy
52. Family history of colorectal cancer as a marker of potential malignancy within a screening program
53. Common inheritance of susceptibility to colonic adenomatous polyps and associated colorectal cancers
54. Colonoscopic screening of persons with suspected risk factors for colon cancer
55. Colonoscopy in patients with a primary family history of colon cancer
56. Heredity and colorectal cancer: A prospective, community-based endoscopic study
57. Colonoscopic screening of asymptomatic patients with a family history of colon cancer
58. Screening endoscopy in patients with family history positive (FH+) for colorectal neoplasia (CRN)
59. Colonoscopic screening examination of relatives of patients with colorectal cancer. I. A comparison with an endoscopically screened normal population
60. Colonic neoplasms in asymptomatic first-degree relatives of colon cancer patients
61. The risk of adenomatous polyps in asymptomatic first-degree relatives of persons with colon cancer
62. Colonoscopic screening in first-degree relatives of patients with sporadic colorectal cancer: A case-control study
63. Cancer risk in relatives of patients with common colorectal cancer
64. Genetics of colon cancer
65. Family history of cancer and colon Cancer risk: The Utah population database
66. Risk of colon cancer associated with a family history of cancer or colorectal polyps: The diet, activity, and reproduction in colon cancer study
67. Colonoscopy in the screening and surveillance of individuals at increased risk for colorectal cancer
68. Hereditary susceptibility to colorectal cancer
69. Large-bowel cancer in married couples in Sweden: A follow-up study
70. Dominant inheritance of adenomatous Colonic polyps and colorectal cancer
71. Alleles of the APC gene: An attenuated form of familial polyposis
72. Genotype-phenotype correlations in attenuated adenomatous polyposis coli
73. Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC
74. Excess risk of colon cancer associated with a polymorphism of the APC gene?
75. The APC l1307K allele and cancer risk in a community-based study of Ashkenazi Jews
76. Prevalence of the I1307K APC gene variant in Israeli Jews of differing ethnic origin and risk for colorectal cancer
77. Germ-line msh6 mutations in colorectal cancer families
78. Association of hereditary nonpolyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations
79. TβR-I(6A) is a candidate tumor susceptibility allele
80. Inherited susceptibility to colorectal adenomas and carcinomas: Evidence for a new predisposition gene on 15q14-q22
81. Colorectal cancer: Molecules and populations
82. Genetic testing in hereditary colorectal cancer: Indicators and procedures
83. A practical approach to familial and hereditary colorectal cancer
84. Genetic testing in hereditary colorectal cancer
85. Genetic testing for susceptibility to adult-onset cancer. The process and content of informed consent
86. Genetic testing and counseling for hereditary forms of colorectal cancer
87. The use and interpretation of commercial APC gene testing for familial adenomatous polyposis
88. Polyposis syndromes
89. Gastrointestinal polyposis syndromes
90. Hereditary nonpolyposis colorectal cancer: The syndrome, the genes, and historical perspective
91. Genetic susceptibility to non-polyposis colorectal cancer
92. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer
93. Care of patients and their families with familial adenomatous polyposis
94. The molecular basis of Turcot's syndrome
95. Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis
96. Hepatoblastoma and APC gene mutation in familial adenomatous polyposis
97. Molecular diagnosis of familial adenomatous polyposis
98. Cancer risk in mutation carriers of DNA-mismatch-repair genes
99. The International Collaborative Group on hereditary non-polyposis colorectal cancer (ICG-HNPCC)
100. Hereditary nonpolyposis colorectal cancer families not complying with the Amsterdam criteria show extremely low frequency of mismatch-repair-gene mutations
101. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the international collaborative Group in HNPCC
102. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer
103. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease
104. Strategies for screening for hereditary non-polyposis colorectal cancer
105. Microsatellite instability in colorectal cancer: Different mutator phenotypes and the principal involvement of hMLH1
106. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma
107. A National Cancer institute Workshop on hereditary nonpolyposis colorectal cancer syndrome: Meeting highlights and Bethesda guidelines
108. Microsatellite instability in human colonic cancer is not a useful clinical indicator of familial colorectal cancer
109. Molecular and phenotypic markers of hamartomatous polyposis syndromes in the gastrointestinal tract
110. Peutz-Jeghers syndrome
111. Peutz-Jeghers syndrome
112. A survey of phenotypic features in juvenile polyposis
113. Cowden syndrome